09.11.2021: We have just published our ‘Annual Report 2021: The Global AMR R&D Funding Landscape’. The report provides a global snapshot of the AMR R&D activities across the full One Health spectrum, offering an evidence base to foster global priority setting and decision making on the allocation of resources. Access the full report here.
24.06.2024
UICC Virtual Dialogue on AMR & Cancer
How can R&D for novel antimicrobial medicines and a secure access pipeline effectively address AMR? On 24th June, Dr. Lesley Ogilvie, the Hub Secretariat Director took part in the Virtual Dialogue: “Addressing Antimicrobial Resistance for Better Cancer Care – The Important Role of R&D”.